SYS-CON MEDIA Authors: Mat Mathews, PR.com Newswire, David Smith, Tim Crawford, Kevin Benedict

News Feed Item

New Hampshire Plastic Surgery Practice Introduces New Volumizing Injectable

Dr. Richard Zeff Now Offers JUVÉDERM VOLUMA XC, the First and Only FDA-Approved Hyaluronic Acid Filler for Treating Age-Related Midfacial Volume Loss

STRATHAM, NH -- (Marketwired) -- 05/01/14 -- New Hampshire plastic surgeon Richard L. Zeff, MD, PA has announced his practice is now offering JUVÉDERM VOLUMA™ XC as an injectable treatment option. Recently approved by the Food and Drug Administration (FDA), JUVÉDERM VOLUMA™ XC is the first and only hyaluronic acid filler approved to treat age-related volume loss in the cheeks and mid-facial region for patients 21 and over.

In a recent blog post on Dr. Zeff's website titled, "Introducing JUVÉDERM VOLUMA™ XC," Cindy Wrocklage, RN, CSPN, nurse injector at the New Hampshire practice, details the distinctions between JUVÉDERM VOLUMA™ XC and other cosmetic injectables, the benefits of treatment, and what patients can expect from the procedure.

According to Dr. Zeff, JUVÉDERM VOLUMA™ XC can be injected into targeted areas using a tiny needle. He says most treatments can be completed during a lunch break, typically only requiring up to 30 minutes of the patient's time. Dr. Zeff notes results generally appear immediately after the procedure, and they can often be expected to last for up to two years.

Dr. Zeff says some aspects of JUVÉDERM VOLUMA™ XC that make this treatment unique compared to other dermal injectables on the market include:

  • Lifting effect - volume can be restored to deflated-looking cheeks, often resulting in a youthful, rejuvenated appearance
  • The only FDA-approved filler of its kind to treat mid-facial volume loss
  • Results are typically longer lasting - 18 months to two years after treatment

Ultimately, Dr. Zeff says this product is approved for anyone over the age of 21 who would like to nonsurgically restore age-related volume loss in the midface. He encourages those who are interested in this anti-aging treatment to consult with an experienced cosmetic surgeon and aesthetic nurse injector.

About Richard L. Zeff, MD, PA
Dr. Zeff, a board-certified plastic surgeon, earned his medical degree from the University of Miami. He completed his surgical internship at New York University Bellevue Hospital and his plastic surgery training at Loyola University Medical Center in Chicago. Dr. Zeff is a member of several respected medical organizations, including the American Society of Plastic Surgeons, the American Society for Aesthetic Plastic Surgery, and the New Hampshire Medical Society. He is available for interview upon request.

To learn more about Dr. Zeff and his practice, please visit drrichardzeff.com or facebook.com/drzeff

To view the original source of this press release, click here: http://www.drrichardzeff.com/blog/dr-richard-zeff/new-hampshire-plastic-surgery-practice-introduces-new-volumizing-injectable/

Image Available: http://www2.marketwire.com/mw/frame_mw?attachid=2581084

Add to Digg Bookmark with del.icio.us Add to Newsvine

Richard L. Zeff, MD, PA
137 Portsmouth Ave.
Stratham, NH 03885
603-684-2339

Rosemont Media
Email Contact
858-200-0044
www.rosemontmedia.com

More Stories By Marketwired .

Copyright © 2009 Marketwired. All rights reserved. All the news releases provided by Marketwired are copyrighted. Any forms of copying other than an individual user's personal reference without express written permission is prohibited. Further distribution of these materials is strictly forbidden, including but not limited to, posting, emailing, faxing, archiving in a public database, redistributing via a computer network or in a printed form.